Skip to main content

Table 1 Demographics of patients

From: Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis

Patients, n 1104
Age (median [IQR]) 69.00 [60.00, 76.00]
Sex
 female 410 (37.1)
 male 694 (62.9)
Stage at diagnosis
 UICC I 34 (3.1)
 UICC II 91 (8.2)
 UICC III 263 (23.8)
 UICC IV 716 (64.9)
Time to metastasis
 DFS < 6 mts 771 (69.8)
 DFS > 6 mts 333 (30.2)
Treatment modality
 best supportive care 274 (24.8)
 resection of metastases only 84 (7.6)
 systemic treatment and resection of metastases 144 (13.0)
 systemic treatment only 602 (54.5)
Treatment lines
 first line treatment 746 (67.6)
 second line treatment 465 (42.1)
 third line treatment 261 (23.6)
RAS-status
 RAS-mutated 453 (41.0)
 RAS-wildtype 426 (38.6)
 unknown 225 (20.4)
BRAF-status (%)
 BRAF-mutated 42 (3.8)
 BRAF-wildtype 364 (33.0)
 unknown 698 (63.2)
MMR-status
 microsatellite instable 26 (2.4)
 microsatellite stable 180 (16.3)
 unknown 898 (81.3)
Location of primary
 colon 699 (64.2)
 rectum 389 (35.8)
 LCC 762 (70.0)
 RCC 326 (30.0)
Organs with metastases
 1 organ 784 (71.0)
 2 or more organs 320 (29.0)
Lung only metastases
 lung only 111 (10.1)
 other than lung only 993 (89.9)
  1. Values are given in n (%) unless not otherwise described; DFS disease free survivial; mts months
\